Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Inc Amgen currently holds 35,368,653 shares of Vigil Neuroscience, Inc. (VIGL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc Amgen has been a net buyer of VIGL stock. They have purchased $429.7M and sold $0 worth of shares.
Inc Amgen's most recent insider trade was on Sep 19, 2023, when they purchased 1,764,705 shares at $17.00 per share.
Inc Amgen serves as Executive at Vigil Neuroscience, Inc. (VIGL). They have executed 21 insider transactions totaling $429.7M over their tenure at the company.
Inc Amgen holds the position of Executive at Vigil Neuroscience, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Inc Amgen has shown a buying trading pattern, with $429.7M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Inc Amgen was on Jul 15, 2020, when they purchased $421.4M worth of BGNE shares. This transaction involved 29,614,832 shares at $14.23 per share.
Inc Amgen currently owns 35,368,653 shares of Vigil Neuroscience, Inc. (VIGL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Inc Amgen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Inc Amgen has 21 Form 4 filings on record as an insider at Vigil Neuroscience, Inc..
Set alerts for Inc Amgen and 40,000+ other insiders.